| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +25,000 | 5.9% | $11.02 | +$275,500 |
| Sells | 6 | -400,997 | 94% | $11.99 | -$4,806,137 |
| Net | -5 | -375,997 | -88% | -$4,530,637 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Joseph Todisco | Chief Executive Officer, Director | $5,469,727 | -$1,010,000 | -16% | 04 Feb 2026 |
| Myron Kaplan | Director | $3,041,093 | +$275,500 | +10% | 26 Jan 2026 |
| Elizabeth Hurlburt | Chief Operating Officer | $1,966,485 | -$711,817 | -27% | 04 Feb 2026 |
| Beth Zelnick Kaufman | Chief Legal Officer | $1,899,902 | -$670,264 | -26% | 04 Feb 2026 |
| Steven W. Lefkowitz | Director | $1,838,737 | -$475,200 | -21% | 26 Jan 2026 |
| Michael David Seckler | Chief Commercial Officer | $1,548,604 | 08 Jan 2026 | ||
| Erin Mistry | EVP, Chief Commercial Officer | $1,130,100 | 10 Jan 2025 | ||
| David Matthew T. | Chief Financial Officer | $1,066,071 | 10 Jan 2025 | ||
| Susan Blum | Chief Financial Officer | $965,012 | 23 Jan 2026 | ||
| Alan W. Dunton | Director | $822,275 | -$391,300 | -32% | 26 Jan 2026 |
| Janet Dillione | Director | $801,609 | -$1,547,556 | -66% | 26 Jan 2026 |
| Gregory Scott Duncan | Director | $799,981 | 26 Jan 2026 | ||
| Robert A. Stewart | Director | $772,848 | 26 Jan 2026 | ||
| Paulo F. Costa | Director | $34,700 | 17 May 2023 | ||
| Phoebe Mounts | General Counsel | $24,984 | 14 Jan 2023 | ||
| Thomas Nusbickel | EVP, Chief Commercial Officer | 18 Feb 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Beth Zelnick Kaufman | CRMD | Common Stock | Award | 15.4% | 36,006 | 269,108 | 04 Feb 2026 | Direct | ||
| Elizabeth Hurlburt | CRMD | Common Stock | Award | 14.8% | 36,006 | 278,539 | 04 Feb 2026 | Direct | ||
| Joseph Todisco | CRMD | Common Stock | Award | 11.1% | 77,156 | 774,749 | 04 Feb 2026 | Direct | ||
| Robert A. Stewart | CRMD | Common Stock | Award | 84.6% | 30,453 | 66,453 | 26 Jan 2026 | Direct | ||
| Janet Dillione | CRMD | Common Stock | Award | 79.2% | 30,453 | 68,926 | 26 Jan 2026 | Direct | ||
| Myron Kaplan | CRMD | Common Stock | Award | 15.2% | 30,453 | 231,487 | 26 Jan 2026 | Direct | ||
| Gregory Scott Duncan | CRMD | Common Stock | Award | 79.4% | 30,453 | 68,786 | 26 Jan 2026 | Direct | ||
| Steven W. Lefkowitz | CRMD | Common Stock | Award | 31.9% | 30,453 | 125,951 | 26 Jan 2026 | Direct | ||
| Alan W. Dunton | CRMD | Common Stock | Award | 75.7% | 30,453 | 70,703 | 26 Jan 2026 | Direct | ||
| Susan Blum | CRMD | Common Stock | Tax liability | -6.85% | -9,767 | 132,739 | 23 Jan 2026 | Direct | ||
| Susan Blum | CRMD | Common Stock | Award | 104.5% | 72,820 | 142,506 | 23 Jan 2026 | Direct | ||
| Beth Zelnick Kaufman | CRMD | Common Stock | Tax liability | -3.64% | -8,803 | 233,102 | 23 Jan 2026 | Direct | ||
| Beth Zelnick Kaufman | CRMD | Common Stock | Award | 43.1% | 72,820 | 241,905 | 23 Jan 2026 | Direct | ||
| Elizabeth Hurlburt | CRMD | Common Stock | Tax liability | -4.25% | -10,778 | 242,533 | 23 Jan 2026 | Direct | ||
| Elizabeth Hurlburt | CRMD | Common Stock | Award | 58% | 93,010 | 253,311 | 23 Jan 2026 | Direct | ||
| Joseph Todisco | CRMD | Common Stock | Tax liability | -3.77% | -27,306 | 697,593 | 23 Jan 2026 | Direct | ||
| Joseph Todisco | CRMD | Common Stock | Award | 45.3% | 225,900 | 724,899 | 23 Jan 2026 | Direct | ||
| Janet Dillione | CRMD | Common Stock | Sale | -20.6% | $68,800 | $6.88 | -10,000 | 38,473 | 21 Jan 2026 | Direct |
| Joseph Todisco | CRMD | Common Stock | Tax liability | -4.34% | -22,665 | 498,999 | 17 Jan 2026 | Direct | ||
| Joseph Todisco | CRMD | Common Stock | Options Exercise | 6.01% | 29,585 | 521,664 | 16 Jan 2026 | Direct | ||
| Joseph Todisco | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -6.71% | -29,585 | 411,245 | 16 Jan 2026 | Direct | ||
| Elizabeth Hurlburt | CRMD | Common Stock | Tax liability | -3.49% | -5,794 | 160,301 | 12 Jan 2026 | Direct | ||
| Joseph Todisco | CRMD | Common Stock | Tax liability | -3.42% | -17,417 | 492,079 | 12 Jan 2026 | Direct | ||
| Steven W. Lefkowitz | CRMD | Common Stock | Options Exercise | 18.6% | 15,000 | 95,498 | 12 Jan 2026 | Direct | ||
| Steven W. Lefkowitz | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -100% | -15,000 | 0 | 12 Jan 2026 | Direct | ||
| Michael David Seckler | CRMD | Common Stock | Award | 133,156 | 133,156 | 08 Jan 2026 | Direct | |||
| Elizabeth Hurlburt | CRMD | Common Stock | Tax liability | -6.16% | -10,895 | 166,095 | 02 Jan 2026 | Direct | ||
| Beth Zelnick Kaufman | CRMD | Common Stock | Tax liability | -6.28% | -11,333 | 169,085 | 02 Jan 2026 | Direct | ||
| Alan W. Dunton | CRMD | Common Stock | Sale | -33.2% | $260,000 | $13.00 | -20,000 | 40,250 | 30 Dec 2025 | Direct |
| Alan W. Dunton | CRMD | Common Stock | Options Exercise | 49.7% | 20,000 | 60,250 | 30 Dec 2025 | Direct | ||
| Alan W. Dunton | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -100% | -20,000 | 0 | 30 Dec 2025 | Direct | ||
| Joseph Todisco | CRMD | Common Stock | Sale | -5.56% | $360,000 | $12.00 | -30,000 | 509,496 | 18 Dec 2025 | Direct |
| Joseph Todisco | CRMD | Common Stock | Options Exercise | 5.89% | 30,000 | 539,496 | 18 Dec 2025 | Direct | ||
| Joseph Todisco | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -7.5% | -30,000 | 370,000 | 18 Dec 2025 | Direct | ||
| Janet Dillione | CRMD | Common Stock | Sale | -41.2% | $408,000 | $12.00 | -34,000 | 48,473 | 09 Dec 2025 | Direct |
| Janet Dillione | CRMD | Common Stock | Options Exercise | 70.1% | 34,000 | 82,473 | 09 Dec 2025 | Direct | ||
| Janet Dillione | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -100% | -34,000 | 0 | 09 Dec 2025 | Direct | ||
| Steven W. Lefkowitz | CRMD | Common Stock | Sale | -33.2% | $475,200 | $11.88 | -40,000 | 80,498 | 09 Dec 2025 | Direct |
| Janet Dillione | CRMD | Common Stock | Sale | -49% | $466,570 | $10.00 | -46,657 | 48,473 | 02 Dec 2025 | Direct |
| Janet Dillione | CRMD | Common Stock | Options Exercise | 96.2% | 46,657 | 95,130 | 02 Dec 2025 | Direct | ||
| Janet Dillione | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -100% | -46,657 | 0 | 02 Dec 2025 | Direct | ||
| Janet Dillione | CRMD | Common Stock | Sale | -35.2% | $261,586 | $9.93 | -26,343 | 48,473 | 24 Nov 2025 | Direct |
| Janet Dillione | CRMD | Common Stock | Options Exercise | 54.4% | 26,343 | 74,816 | 24 Nov 2025 | Direct | ||
| Janet Dillione | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -100% | -26,343 | 0 | 24 Nov 2025 | Direct | ||
| Janet Dillione | CRMD | Common Stock | Sale | -38.2% | $342,600 | $11.42 | -30,000 | 48,473 | 14 Nov 2025 | Direct |
| Myron Kaplan | CRMD | Common Stock | Purchase | 14.2% | $275,500 | $11.02 | 25,000 | 201,034 | 23 Oct 2025 | Direct |
| Gregory Scott Duncan | CRMD | Common Stock | Options Exercise | 53.3% | 13,333 | 38,333 | 16 Sep 2025 | Direct | ||
| Gregory Scott Duncan | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | -66.7% | -13,333 | 6,667 | 16 Sep 2025 | Direct | ||
| Alan W. Dunton | CRMD | Common Stock | Sale | -19.9% | $131,300 | $13.13 | -10,000 | 40,250 | 12 Sep 2025 | Direct |
| Alan W. Dunton | CRMD | Common Stock | Options Exercise | 24.8% | 10,000 | 50,250 | 12 Sep 2025 | Direct |